0001562180-21-005842.txt : 20210903
0001562180-21-005842.hdr.sgml : 20210903
20210903185253
ACCESSION NUMBER: 0001562180-21-005842
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woock John
CENTRAL INDEX KEY: 0001756437
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 211237848
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-09-01
false
0001603756
Axonics, Inc.
AXNX
0001756437
Woock John
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
Chief Marketing Officer
Common Stock
2021-09-01
4
M
false
5000.00
1.63
A
34932.00
D
Common Stock
2021-09-01
4
S
false
8443.00
74.7264
D
26489.00
D
Common Stock
2021-09-02
4
S
false
1557.00
75.5793
D
24932.00
D
Stock Option (Right to Buy)
1.63
2021-09-01
4
M
false
3443.00
0.00
D
2028-03-30
Common Stock
3443.00
12757.00
D
Stock Option (Right to Buy)
1.63
2021-09-02
4
M
false
1557.00
0.00
D
2028-03-30
Common Stock
1557.00
11200.00
D
This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 15, 2021.
This transaction was executed in multiple trades at prices ranging from $73.82 to $75.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $75.00 to $76.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
/s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
2021-09-03